Anzu Partners — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
North Andover, US
Aaron Bent(Director)
Board seatDavid Michael· per SEC Form D · $10.1M raise · filed Jan 2021
BiotechCambridge, US
ANDREW SANDFORD(Executive Officer, Director)ALEX KOGLIN(Director)THOMAS NICKOLOFF(Director)
Board seatDavid Seldin· per SEC Form D · $7M raise · filed Sep 2021
Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows.
BiotechDeep TechHardwareBillerica, US
Bryan Hassell(Executive Officer)inJonathan Hartmann(Chief Executive Officer)John C. Ho(Director)in
BoardDavid Michael(Director)inMatthew Gunnison(Director)
Board seatDavid SeldinJohn Ho· per SEC Form D · $9.7M raise · filed Jun 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.